Evidence map›Paper›PMID 34570315›Full record

Trial reportAIDS and behavior2022

Increased Depression during COVID-19 Lockdown Associated with Food Insecurity and Antiretroviral Non-Adherence among People Living with HIV in Uganda.

Glenn J Wagner, Zachary Wagner, Mahlet Gizaw, Uzaib Saya, Sarah MacCarthy, Barbara Mukasa, Peter Wabukala, Sebastian Linnemayr

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. "Journal of ageing and longevity · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Glenn J WagnerRAND Corporation, 1776 Main St., Santa Monica, CA, 90407, USA. gwagner@rand.org.ORCID http://orcid.org/0000-0001-9081-3299
Zachary WagnerRAND Corporation, 1776 Main St., Santa Monica, CA, 90407, USA.
Mahlet GizawRAND Corporation, 1776 Main St., Santa Monica, CA, 90407, USA.
Uzaib SayaRAND Corporation, 1776 Main St., Santa Monica, CA, 90407, USA.
Sarah MacCarthyRAND Corporation, 1776 Main St., Santa Monica, CA, 90407, USA.
Barbara MukasaMildmay Uganda, Kampala, Uganda.
Peter WabukalaMildmay Uganda, Kampala, Uganda.
Sebastian LinnemayrRAND Corporation, 1776 Main St., Santa Monica, CA, 90407, USA.
RAND Corporation · USMildmay Uganda · UG

Funding

Behavioral Economics Incentives to Support HIV Treatment Adherence in Sub-Saharan AfricaR01MH110350 · NIMH · RAND CORPORATION · PI LINNEMAYR, SEBASTIAN · 2017 to 2021
$2.8M
NIMH NIH HHS R01 MH110350NIMH NIH HHS R01MH110350
6 · The paper itself

Abstract

The health and economic threats posed by the COVID-19 pandemic can be sources of great distress among people living with HIV, which in turn can impact the management of their HIV disease. We examined change in depression from pre- to post-lockdown restrictions and correlates of elevated depressive symptoms, including antiretroviral therapy (ART) adherence. Participants enrolled in a randomized controlled trial of an ART adherence intervention in Uganda. The month-12 follow-up assessment was fully administered just prior to the start of the pandemic-related lockdown in March 2020; at the conclusion of the lockdown three months later, we administered a mixed-methods phone-based assessment. ART adherence was electronically monitored throughout the study period, including during and after the lockdown. Depression was assessed with the 8-item Patient health questionnaire (PHQ-8), on which scores > 9 signify a positive screen for elevated depressive symptoms. A sample of 280 participants completed both the month-12 and post-lockdown assessments. Rates of elevated depressive symptoms nearly tripled from month 12 (n = 17, 6.1%) to the post-lockdown assessment (n = 50, 17.9%; McNemar test < .001). Elevated depressive symptoms at post-lockdown were associated with being female, indicators of economic struggles at month 12 (unemployment, low income, high food insecurity), and lower ART adherence during the 3-month lockdown period [mean of 71.9% (SD = 27.9) vs. 80.8% (SD = 24.1) among those not depressed; p = .041] in bivariate analysis. In multiple regression analysis, higher food insecurity [adj. OR (95% CI) = 4.64 (2.16-9.96)] and perception that the pandemic negatively impacted ART adherence [adj. OR (95% CI) = 1.96 (1.22-3.16)] remained associated with a greater likelihood of elevated depressive symptoms, when other correlates were controlled for. Qualitative data suggested that economic stressors (lack of food, work, and money) were key contributors to elevated depressive symptoms, and these stressors led to missed ART doses because of lack of food and stress induced forgetfulness. Elevated depressive symptoms significantly increased during the COVID-19 lockdown and was associated with food insecurity and reduced ART adherence. Mechanisms for identifying and treating depression and food insecurity are needed to help PLHIV cope with and mitigate the harmful effects of unexpected crises that may impede disease management and access to food.

Indexed as

COVID-19HIV InfectionsAnti-Retroviral AgentsCommunicable Disease ControlDepressionFemaleFood InsecurityFood SupplyHumansMalePandemicsUgandaAnti-Retroviral AgentsAdherenceCOVID-19DepressionEconomicFood insecurityHIVUganda

Identifiers

PMID34570315
PMCPMC8475428
OpenAlexW3201709436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.